Department of Doctoral Studies, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Dr. D Medical Center, Center for Advanced Ultrasound Evaluation, Timisoara, Romania.
Front Endocrinol (Lausanne). 2024 May 28;15:1393982. doi: 10.3389/fendo.2024.1393982. eCollection 2024.
Fine needle aspiration (FNA) is the gold standard method recommended in the diagnosis of thyroid nodules. Bethesda IV cytology results are identified in 7-9% of nodules investigated through FNA, with reported malignancy rate in a wide range of 10-40%. The recommended treatment is either surgical or risk additional molecular testing before surgery. However, a large number of nodules belonging to this category (60-80%) are observed to be benign after surgical excision, which can put the patient at risk of unnecessary surgical morbidity. This study aimed to assess the diagnostic performance of conventional ultrasound, the ACR TI-RADS score and elastography in cases of Bethesda IV cytology on FNA.
We evaluated ninety-seven consecutive cases with Bethesda category IV results on FNA by using conventional B-mode ultrasound, qualitative strain or shear-wave elastography (Hitachi Preirus Machine, Hitachi Inc., Japan and Aixplorer Mach 30 Supersonic Imagine, Aix-en-Provence, France) and all nodules were classified according to the ACR TI-RADS system. Conventional ultrasound was used to categorize the nodules as potentially malignant based on the following features: hypoechogenicity, inhomogeneity, a taller than wide shape, irregular margins, presence of microcalcifications, an interrupted thyroid capsule and suspicious cervical lymph nodes. Elastography classified nodules with increased stiffness as suspicious for malignancy.
We considered pathology results as the gold standard diagnosis, finding that 32 out of 97 nodules were carcinomas (33%) and 65 out of 97 were benign nodules (67%). The benign group included twenty cases of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Finally, we compared ultrasound data with pathology results, which showed that nineteen out of the 32 malignant nodules presented with increased stiffness on elastography (p=0.0002). On conventional ultrasound, we found that microcalcifications (p=0.007), hypoechogenicity and irregular margins (p=0.006) are features which can distinguish between benign and malignant nodules with statistical significance.
Integrating elastography as a parameter of the ACR TI-RADS score in the evaluation of Bethesda category IV nodules showed a sensitivity of 90.62% in detecting thyroid cancer cases (p=0.006). We can conclude that elastographic stiffness as an addition to high risk features observed on conventional ultrasound improves the detection of malignant nodules in cases with Bethesda IV cytology.
细针穿刺抽吸术(FNA)是诊断甲状腺结节的金标准方法。通过 FNA 检查,有 7-9%的结节被诊断为 Bethesda IV 级细胞学结果,报告的恶性肿瘤发生率范围很广,为 10-40%。推荐的治疗方法是手术或在手术前进行额外的分子检测。然而,大量属于这一类的结节(60-80%)在手术后被观察为良性,这可能使患者面临不必要的手术发病率的风险。本研究旨在评估在 FNA 中出现 Bethesda IV 级细胞学结果时,常规超声、ACR TI-RADS 评分和弹性成像的诊断性能。
我们通过常规 B 型超声、定性应变或剪切波弹性成像(日立 Preirus 机器,日立公司,日本和 Aixplorer Mach 30 Supersonic Imagine,艾克斯普罗旺斯,法国)评估了 97 例连续 FNA 检查为 Bethesda 四级的病例,并根据 ACR TI-RADS 系统对所有结节进行分类。常规超声根据以下特征将结节分类为潜在恶性:低回声、不均匀性、高宽比、不规则边缘、微钙化、甲状腺包膜中断和可疑颈部淋巴结。弹性成像将硬度增加的结节分类为恶性可疑。
我们将病理结果视为金标准诊断,发现 97 个结节中有 32 个为癌(33%),65 个为良性结节(67%)。良性组包括 20 例具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)。最后,我们将超声数据与病理结果进行比较,结果显示 32 个恶性结节中有 19 个在弹性成像上表现出硬度增加(p=0.0002)。在常规超声中,我们发现微钙化(p=0.007)、低回声和不规则边缘(p=0.006)是具有统计学意义的可以区分良恶性结节的特征。
将弹性成像作为 ACR TI-RADS 评分的参数纳入 Bethesda 四级结节的评估中,在检测甲状腺癌病例时显示出 90.62%的敏感性(p=0.006)。我们可以得出结论,弹性成像硬度作为常规超声观察到的高危特征的补充,提高了 Bethesda IV 级细胞学病例中恶性结节的检出率。